or Try an Advanced Search...

    Technical Analysis for DTIL - Precision BioSciences, Inc.

    Grade Last Price % Change Price Change
    F 9.38 -3.50% -0.34
    DTIL closed down 3.5 percent on Friday, April 26, 2024, on 19 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical DTIL trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -3.50%
    NR7-2 Range Contraction -3.50%
    Narrow Range Bar Range Contraction -3.50%
    Multiple of Ten Bearish Other -3.50%
    Wide Bands Range Expansion -3.50%
    Oversold Stochastic Weakness -3.50%
    180 Bearish Setup Bearish Swing Setup -4.48%
    Older End-of-Day Signals for DTIL ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 13 hours ago
    Down 2 % about 13 hours ago
    Possible NR7 about 15 hours ago
    60 Minute Opening Range Breakout about 17 hours ago
    Up 1% about 17 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    DTIL Chart by TradingView
    Basic chart:

    Profile

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing

    Is DTIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 17 Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?
    Apr 16 Eli Lilly subsidiary, Precision Biosciences end gene therapy collaboration
    Apr 16 Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
    Apr 11 Precision BioSciences (DTIL) Now Trades Above Golden Cross: Time to Buy?
    Apr 2 Wall Street Analysts Predict a 407.94% Upside in Precision BioSciences (DTIL): Here's What You Should Know
    Apr 2 Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?
    Mar 27 Precision BioSciences (DTIL) Reports Q4 Loss, Lags Revenue Estimates
    Mar 27 Precision BioSciences GAAP EPS of -$4.06 misses by $2.03, revenue of $7.04M misses by $7.42M
    Mar 27 Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
    Mar 27 Earnings Scheduled For March 27, 2024
    See more DTIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.015
    52 Week Low 8.25
    Average Volume 152,030
    200-Day Moving Average 12.61
    50-Day Moving Average 12.73
    20-Day Moving Average 12.52
    10-Day Moving Average 10.67
    Average True Range 0.99
    RSI (14) 32.89
    ADX 24.1
    +DI 16.43
    -DI 33.51
    Chandelier Exit (Long, 3 ATRs) 13.01
    Chandelier Exit (Short, 3 ATRs) 12.11
    Upper Bollinger Bands 16.72
    Lower Bollinger Band 8.32
    Percent B (%b) 0.13
    BandWidth 67.06
    MACD Line -0.93
    MACD Signal Line -0.50
    MACD Histogram -0.4277
    Fundamentals Value
    Market Cap 1.14 Billion
    Num Shares 122 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -10.91
    Price-to-Sales 0.94
    Price-to-Book 1.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.31
    Resistance 3 (R3) 10.41 10.21 10.16
    Resistance 2 (R2) 10.21 9.97 10.16 10.10
    Resistance 1 (R1) 9.79 9.82 9.69 9.69 10.05
    Pivot Point 9.59 9.59 9.54 9.54 9.59
    Support 1 (S1) 9.17 9.35 9.07 9.07 8.71
    Support 2 (S2) 8.97 9.20 8.92 8.66
    Support 3 (S3) 8.55 8.97 8.61
    Support 4 (S4) 8.45